1. How myosin organization of the actin cytoskeleton contributes to the cancer phenotype
   Michelle Peckham, 2016, Biochemical Society Transactions CrossRef
2. MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development
   Xingwang Xie et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
3. Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis
   Shahid Hussain et al, 2018, PLOS ONE CrossRef
4. Tumor Stiffness Is Unrelated to Myosin Light Chain Phosphorylation in Cancer Cells
   Hui-Jun Yu et al, 2013, PLoS ONE CrossRef
5. Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response
   D. Dvornikov et al, 2018, Scientific Reports CrossRef
6. Long noncoding RNA HAR1A regulates oral cancer progression through the alpha-kinase 1, bromodomain 7, and myosin IIA axis
   Chi-Pin Lee et al, 2021, Journal of Molecular Medicine CrossRef
7. Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation
   Dechao Feng et al, 2022, Heliyon CrossRef
8. Specific cytotoxic T‐cell immune responses against autoantigens recognized by chronic lymphocytic leukaemia cells
   Joanna Zaleska et al, 2016, British Journal of Haematology CrossRef
9. The Expressions and Mechanisms of Sarcomeric Proteins in Cancers
   Xiaojing Yang et al, 2020, Disease Markers CrossRef
10. Myosins: Driving us towards novel targets and biomarkers in cancer
    Eric Koncina et al, 2020, Actin Cytoskeleton in Cancer Progression and Metastasis - Part B CrossRef
11. Single-cell RNA-sequencing analysis reveals MYH9 promotes renal cell carcinoma development and sunitinib resistance via AKT signaling pathway
    Zhipeng Xu et al, 2022, Cell Death Discovery CrossRef
12. Myosins and Disease
    Lynne M. Coluccio, 2020, Myosins CrossRef
13. HBXIP blocks myosin-IIA assembly by phosphorylating and interacting with NMHC-IIA in breast cancer metastasis
    Lu Zhang et al, 2023, Acta Pharmaceutica Sinica B CrossRef
14. Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
    Karen A. Newell-Litwa et al, 2015, Disease Models & Mechanisms CrossRef
15. Prognostic impact of MYH9 expression on patients with acute myeloid leukemia
    Mengxia Yu et al, 2017, Oncotarget CrossRef
16. Bladder Cancer Biomarkers: Review and Update
    Soudeh Ghafouri-Fard et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
17. Prognostic Significance of MYH9 Expression in Resected Non-Small Cell Lung Cancer
    Ken Katono et al, 2015, PLOS ONE CrossRef
18. Quantitative Proteomic Analysis Identifies CPNE3 as a Novel Metastasis-promoting Gene in NSCLC
    He-chun Lin et al, 2013, Journal of Proteome Research CrossRef
19. The mechanobiome: a goldmine for cancer therapeutics
    Eleana Parajón et al, 2021, American Journal of Physiology-Cell Physiology CrossRef
20. Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy
    HAIJIAO JIANG et al, 2015, Molecular Medicine Reports CrossRef